Identification of serum protein biomarkers for clear cell renal cell carcinoma using patient-derived xenografts
We have identified a serum biomarker panel for clear cell renal cell carcinoma that suitable for clinical applications such as diagnosis and monitoring treatment response.
Authors
- Christian R. Hoerner (ORCID: https://orcid.org/0000-0002-8685-1126)
- Sharon J. Pitteri (ORCID: https://orcid.org/0000-0002-3119-873X)
- E H Wang
- James D. Brooks (ORCID: https://orcid.org/0000-0003-4521-7505)
- N. Hannaoui Hadi
- Robert John Tibshirani (ORCID: https://orcid.org/0000-0003-0553-5090)
- Alice C. Fan (ORCID: https://orcid.org/0000-0002-4813-5444)
- John T. Leppert (ORCID: https://orcid.org/0000-0001-9980-3863)
- Chun-Lung Chiu (ORCID: https://orcid.org/0000-0001-7514-9676)
- Fernando Jose Garcia-Marques (ORCID: https://orcid.org/0000-0002-2105-2905)
- Thomas J. Metzner (ORCID: https://orcid.org/0000-0002-8959-7557)
- Ludimila Trabanino
- Hongjuan Zhao
- Abel Bermudez (ORCID: https://orcid.org/0009-0002-3235-5538)
- Dalin Zhang
Institutions
- National Pingtung University of Science and Technology (TW)
- Caporal Assistance Network (US)
- Stanford Medicine (US)
- Stanford University (US)
Publication Details
- Journal
- Journal of Clinical Investigation
- Published
- 2025-11-04
- DOI
- https://doi.org/10.1172/jci193567
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00